Cebix's Grant

Cebix raised a round of funding on June 21, 2009. Investors include Qualifying Therapeutic Discovery Project.

Cebix is developing Ersatta, a disease-modifying replacement peptide for the treatment of complications associated with diabetes. Ersatta is a long-acting form of C-peptide that, unlike other products…

Articles about Cebix's Grant: